Modifizierter Antikörper

Patent europeic · EP2862878 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2862878
Numer da la dumonda
EP14195614
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-02-2004
Publitgà
22-04-2015
Concedì
02-11-2022
Stritgà
23-09-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 16/46 (2006.01)
Prioritad
US 450134 P 25.02.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.09.2023

  2. 13-09-2023

    Midada

    Published in Swissreg on 13.09.2023

  3. 02-11-2022

    Concedì

    Published in Swissreg on 02.11.2022

Partidas

Possessur

Nykode Therapeutics ASA

Gaustadalléen 21, 0349 Oslo, NO

Inventur

Bogen, Bjarne

1367 Snarøya, NO

Fredriksen, Agnete Brunsvik

2005 Rællingen, NO

Sandlie, Inger

0752 Oslo, NO

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.